INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • August 12th, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • New York
This Intellectual Property Security Agreement (“Agreement”) is executed on August 12, 2024 by Elicio Therapeutics, Inc., a Delaware corporation (together with its successors and assigns, “Grantor”), in favor of GKCC, LLC (the “Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 12th, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of August 12, 2024, by and among Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”).
SUBSIDIARY GUARANTEESubsidiary Guarantee • August 12th, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • New York
This SUBSIDIARY GUARANTEE, dated as of August 12, 2024 (this “Guarantee”), is made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the holders (together with their permitted assigns, the “Purchasers”) of the Senior Secured Convertible Promissory Notes in the principal amount of $20,000,000.00 (the “Notes”) of Elicio Therapeutics, Inc., a Delaware corporation (the “Company”).
SECURITY AGREEMENTSecurity Agreement • August 12th, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations
SECURITY AGREEMENT, dated August 12, 2024, by and between Elicio Therapeutics, Inc., a Delaware corporation, with headquarters located at 451 D Street, 5th Floor, Boston, Massachusetts 02210 (the “Debtor”), and the investors set forth on Schedule A hereof (collectively, the “Secured Party”).
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUE FEBRUARY 15, 2026Elicio Therapeutics, Inc. • August 12th, 2024 • Pharmaceutical preparations • New York
THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is the duly authorized and validly issued convertible promissory note of Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), having its principal place of business at 451 D Street, 5th Floor, Boston, Massachusetts 02210, designated as its Senior Secured Convertible Promissory Note due February 15, 2026 (the “Note”).
